A supplement formulation may perform very well in a small test batch and then begin to cause problems when production is scaled up. The mixture may flow differently, become harder to keep homogeneous, generate more dust, or show greater variation during dosing. This does not necessarily mean that the formulation itself was developed incorrectly. Very often, the issue is caused by changes in process conditions that occur as production scale increases.
This is one of the most important differences between preparing a few kilograms of a mixture and manufacturing a much larger commercial batch. Scaling up is not simply a matter of multiplying every ingredient by the same factor. The mixing method, order of ingredient addition, process time, equipment parameters and material transfer between production stages may also need to be reassessed.
Why Is Simple Mathematical Scaling Not Always Enough?
If a formulation contains fixed ingredient proportions, increasing the batch size mathematically is relatively straightforward. The problem is that the technological process does not scale in exactly the same way.
A larger quantity of material behaves differently inside a mixer, during transfer and in dosing equipment. The fill level of the machine changes, the way powder moves within the equipment changes, the time required to achieve homogeneity may differ, and there are more opportunities for ingredients to segregate.
For this reason, moving from a pilot batch to full-scale manufacturing should be treated as a separate technological stage rather than simply increasing the quantities of all raw materials.
A Larger Mixer Means Different Processing Conditions
A laboratory mixer and an industrial production mixer are not simply the same machine in two different sizes. The geometry of the chamber, the way material moves and the ratio between equipment surface area and mixture volume all change.
In a small batch, ingredients may become evenly distributed very quickly. In a much larger mass, the same mixing time may be insufficient.
The opposite may also occur. Mixing for too long does not always improve homogeneity. In some systems, prolonged mixing can encourage ingredients with different particle sizes or densities to separate again.
This is why powder blending requires not only the right equipment but also correctly defined processing parameters for the specific formulation.
Differences in Particle Size Increase the Risk of Segregation
One of the biggest challenges in the production of powder blends is maintaining an even distribution of all ingredients. The problem becomes especially important when individual raw materials differ significantly in particle size.
Finer particles may move between larger particles, while heavier components may behave differently from lighter powders with a low bulk density.
In a small sample, this effect may be almost impossible to notice. In a larger mass, during longer mixing and additional transfer stages, the risk of segregation may become more significant.
Bulk Density Affects Mixture Behaviour
Two ingredients with the same weight may occupy very different volumes. This is partly due to differences in bulk density.
If a formulation contains raw materials with very different physical properties, their behaviour in a large mixer may differ from what was observed during small-scale preparation.
The density of the mixture also matters during later processing stages. It can influence encapsulation, sachet filling and other portioning methods.
If the physical properties of the powder change between stages, this may affect dosing consistency.
The Order of Ingredient Addition Can Matter
In simple formulations, the order in which raw materials are added may not always be critical. In more complex formulations, however, the situation is different.
If a very small amount of an active ingredient has to be distributed evenly throughout a much larger mass of other components, adding the entire amount directly to a large mixer may make it more difficult to achieve uniformity.
In such cases, it may be necessary to prepare a premix in stages and gradually increase its volume before combining it with the full batch.
This is a good example of why a process developed at laboratory scale must be properly translated into real production conditions.
Material Transfer Between Machines Can Also Change the Blend
Once mixing is complete, the powder usually moves to the next stage of production. It may be transferred for encapsulation, tableting, sachet filling or packaging.
Every transfer and pouring operation can cause the material to move and separate again. Vibration, free falling of powder and transfer into subsequent containers may encourage particles with different sizes and densities to segregate.
This is why achieving good homogeneity immediately after mixing is not always enough. The behaviour of the product during the rest of the process should also be considered.
Dusting May Become Much More Noticeable at Larger Scale
A raw material that appears easy to handle during preparation of a small sample may generate much more dust during full-scale manufacturing.
This results partly from the larger mass of material and partly from the greater number of technological operations. Opening bags, weighing, pouring, mixing and transferring all create more opportunities for fine particles to become airborne.
Dusting can affect process organisation, material losses and the ability to maintain suitable production conditions.
For this reason, dust-generating properties should also be assessed when a formulation is scaled up.
The Smaller the Ingredient Proportion, the Greater the Homogeneity Challenge
Formulations in which one ingredient is present in a very small amount compared with the total product mass can be particularly demanding.
If only a small quantity of one component is distributed throughout a large production batch, that component must be dispersed very evenly across the entire mixture.
At larger scale, even small local differences may become more significant. In these formulations, premix preparation, processing sequence and mixing parameters become especially important.
Dosing Repeatability Depends on the Physical Properties of the Powder
Chemical homogeneity is not the only requirement. The product should also behave in a way that allows consistent portioning.
If the powder flows freely at one point but later begins to form compacted structures or bridge inside a hopper, maintaining similar fill quantities in successive capsules or sachets may become more difficult.
The behaviour of the powder is influenced by factors such as:
- flowability,
- bulk density,
- moisture content,
- tendency to cake,
- electrostatic properties,
- particle size distribution.
Technological evaluation of the formulation should therefore include not only the ability to mix the ingredients but also their behaviour during later dosing operations.
Why Might a Larger Batch Require a Different Mixing Time?
Mixing time should not automatically be increased in direct proportion to product mass. A batch that is twice as large does not necessarily require twice as much mixing time.
The correct duration depends on equipment design, fill level, raw material properties and the way the material moves within the system.
Processing parameters should therefore be based on the actual production process rather than on simple calculations.
A Pilot Batch Should Answer Specific Questions
A properly prepared technological trial is not intended only to assess the taste, smell or appearance of a supplement. It should also provide information needed for later full-scale manufacturing.
It is useful to evaluate:
- the flowability of the finished mixture,
- the tendency of ingredients to segregate,
- the level of dust generation,
- behaviour during transfer,
- dosing consistency,
- changes occurring during intermediate storage.
Documenting the Process Helps Maintain Repeatability
If the outcome of production depended mainly on the experience of a particular operator, it would be difficult to achieve similar results from one batch to the next.
This is why key processing parameters should be defined, monitored and documented. This includes factors such as mixing time, the order in which raw materials are added, the way the product is transferred and dosing settings.
This approach helps reduce unintended variation between successive production batches.
Scaling Is Part of Product Development
A formulation that performs well in a small-scale trial is an important starting point. It does not, however, guarantee that it will behave identically in a significantly larger batch.
As production scale increases, mixing, transfer and dosing conditions change. Differences in particle size, density and flowability also become more important.
For this reason, successful scale-up should combine formulation development with process technology. Only then can it be determined whether a product is suitable for stable and repeatable commercial manufacturing.
FAQ
Is it enough to increase all ingredient quantities proportionally in a larger production batch?
Not always. The formulation proportions can remain the same, but process parameters such as mixing, transfer and dosing may need to be adjusted.
Why can a larger batch be less homogeneous?
Possible causes include differences in particle size and density, mixer geometry, the order of ingredient addition and segregation during material transfer.
Does longer mixing always improve homogeneity?
No. The optimal mixing time depends on the specific formulation and equipment. In some cases, excessive mixing can also negatively affect the behaviour of the blend.
Why is a pilot batch useful before full-scale manufacturing?
It makes it possible to assess not only the formulation itself but also flowability, dusting, homogeneity, behaviour during transfer and the ability to dose the product consistently.